by Proactive LTC Consulting | Jun 25, 2025 | Compliance, Documentation, Emergency Preparedness, Survey
Is Your Facility Truly Prepared for an Emergency? The OIG Says “Maybe Not” Nursing homes play a vital role in keeping vulnerable residents safe, but recent emergencies in facilities (e.g., hurricanes, infectious outbreaks, fires) have revealed critical... by Proactive LTC Consulting | Jun 18, 2025 | 5-Star, Medicare, QAPI, Quality, Quality Measure, Staffing, Survey
CMS Announces Major Updates to Nursing Home Care Compare CMS released QSO-25-20-NH on June 18, 2025, detailing several important updates that will impact how nursing home performance is displayed on Nursing Home Care Compare. These changes aim to provide a more... by Proactive LTC Consulting | Jun 18, 2025 | Care Planning, Clinical, Compliance, QAPI, Regulatory, Survey
QAPI & Health Equity: What New Surveyor Guidance Means for Nursing Homes If you’ve worked in long-term care for more than a minute, you understand that QAPI is the backbone of quality improvement. But there’s a new layer added with the recent CMS... by Proactive LTC Consulting | Jun 11, 2025 | Clinical, Compliance, F-Tag, Nursing, Survey
F761 – Maintaining Compliance through Strong Partnerships Maintaining compliance with F761 – Storage and Labeling of Drugs and Biologicals requires ensuring medications are properly stored, secured, and destroyed based on state and federal guidelines.... by Proactive LTC Consulting | Jun 4, 2025 | Compliance, Elopement, Falls, Pressure Ulcers, QAPI, Quality, Regulatory, Survey
Learning from Adverse Events & Incidents Studies show that nearly one in three skilled nursing facility residents experience an adverse event during their stay, with approximately 60% of these events being potentially preventable. Adverse events in skilled... by Proactive LTC Consulting | May 28, 2025 | Clinical, Compliance, F-Tag, Pharmacy, Regulatory, Survey
Q: What are the most common reasons for the citing of F761 – Storage of Drugs and Biologicals? A: In Appendix PP the regulatory guidance for F761 is as follows: §483.45(g) Labeling of Drugs and Biologicals Drugs and biologicals used in the facility must be...